Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients.
Overview publication
Title | Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients. |
Date | 2024-11-01 |
Issue name | Expert review of clinical immunology |
Issue number | v20.11:1293-1295 |
DOI | 10.1080/1744666X.2024.2384703 |
PubMed | 39041826 |
Authors | |
Keywords | anakinra, steroid naïve, systemic idiopathic juvenile arthritis, window of opportunity |
Read | Read publication |